Long-term follow-up of cytogenetically normal CEBPA-mutated AML.
Pastore F, Kling D, Hoster E, Dufour A, Konstandin NP, Schneider S, Sauerland MC, Berdel WE, Buechner T, Woermann B, Braess J, Hiddemann W, Spiekermann K.
Pastore F, et al. Among authors: hoster e.
J Hematol Oncol. 2014 Sep 10;7:55. doi: 10.1186/s13045-014-0055-7.
J Hematol Oncol. 2014.
PMID: 25214041
Free PMC article.
Clinical Trial.